Ziva Mesika
Algemeen Adviseur bij NEURODERM LTD
Oorsprong van het eerstegraads netwerk van Ziva Mesika
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Subsidiary | Biotechnology | 20 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Ziva Mesika via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| INTERPACE BIOSCIENCES, INC. | Medical Specialties | Chief Executive Officer | |
| MONSANTO | Wholesale Distributors | Corporate Officer/Principal | |
| ON TRACK INNOVATIONS LTD. | Computer Processing Hardware | Comptroller/Controller/Auditor | |
OMRIX Biopharmaceuticals, Inc.
 OMRIX Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OMRIX Biopharmaceuticals, Inc. specializes in the manufacture and development of biosurgical and passive immunotherapy products. Its product range encompasses hemostatic, surgical, and immunotherapy solutions. The firm offers solutions for bleeding control, surgical operations, and biodefense applications. The company was founded by Robert Taub in 1995 and is headquartered in Somerville, NJ. | Pharmaceuticals: Major | Chairman Founder | |
| OWC PHARMACEUTICAL RESEARCH CORP. | Miscellaneous | Chief Tech/Sci/R&D Officer | |
| MITSUBISHI TANABE PHARMA CORPORATION | Pharmaceuticals: Other | Corporate Officer/Principal | |
Oridion Systems Ltd.
 Oridion Systems Ltd. Medical SpecialtiesHealth Technology Oridion Systems Ltd. develops medical devices for patient safety monitoring. It produces medical devices (hardware) and patient interfaces (consumables) based on its patented Microstream and Smart Capnography technologies for the enhancement of patient safety and clinical outcomes. It provides solutions for respiratory monitoring and airway management for patients which includes non-incubated patients, premature newborns and clinical environments which includes procedural sedation, pain management, critical care units, post-anesthesia care units, emergency medical services, transport and alternate care. It operates in Jerusalem, Israel, Needham, Massachusetts and the United States of America. The company was founded by Yacov Bubis in 1987 and is headquartered in Jerusalem, Israel. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| W.R. Grace & Co. /Agracetus Transgenic Plant Division/ | Food: Major Diversified | Chief Executive Officer | |
| Lehigh University | College/University | Undergraduate Degree | |
| INSEAD | College/University | Masters Business Admin | |
| University of Connecticut | College/University | Masters Business Admin | |
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Tel-Aviv University operates as a university in Israel. Its faculties include arts, engineering, science, humanities, law, life science, management, medicine, and social science. The company was founded in 1956 and is headquartered in Ramat Aviv, Israel. | College/University | Doctorate Degree | |
| Technion-Israel Institute of Technology | College/University | Graduate Degree Graduate Degree | |
| The Hebrew University of Jerusalem | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
| CALLIDITAS THERAPEUTICS AB | Pharmaceuticals: Major | Corporate Officer/Principal | |
TransPharma Medical Ltd.
 TransPharma Medical Ltd. Pharmaceuticals: MajorHealth Technology Established in 2000, TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transversal drug delivery technology. Its current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transversal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1. TransPharma's drug-product development activities utilize its well-proven RF-MicroChannel Technology. Its RF-MicroChannel technology enables the creation of an array of microscopic pores through the very outer skin surface, allowing the delivery of therapeutic doses of a wide portfolio of drugs, including biologics, Its main area of focus. TransPharma's implementation of the RF-MicroChannel Technology is the ViaDerm delivery system. Intended for home use, the ViaDerm delivery system consists of a reusable, handheld, low-cost device and a disposable patch containing a drug. TransPharma's goal is to develop multiple drug-products through strategic partnerships with leading pharmaceutical companies and through independent product development. They believe that combining partnered and proprietary product development ensures capitalizing of both the promise of its technology and its growing capabilities. | Pharmaceuticals: Major | Director/Board Member | |
| Bar-Ilan University | College/University | Doctorate Degree Graduate Degree Masters Business Admin | |
PricewaterhouseCoopers (Israel)
 PricewaterhouseCoopers (Israel) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers (Israel) provides legal services. The company is based in Tel Aviv, Israel. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Ben-Gurion University of the Negev | College/University | Doctorate Degree | |
Teva SA
 Teva SA BroadcastingConsumer Services Teva SA operates a mini generalist television channel. It offers music, serials, animations and comedy programs. The firm is engaged in terrestrial television broadcasting, together with program production and other broadcasting related activities. Teva was founded in 1987 and is headquartered in Neuilly-sur-Seine. | Broadcasting | Corporate Officer/Principal | |
| BIOLINERX LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| B. GAON HOLDINGS LTD. | Financial Conglomerates | Director/Board Member | |
| GEFFEN RESIDENCE & RENEWAL LTD | Agricultural Commodities/Milling | Corporate Officer/Principal | |
G.I. View Ltd.
 G.I. View Ltd. Medical SpecialtiesHealth Technology G.I. View Ltd. develops endoscopy products for gastrointestinal applications. It offers edge endoscopes for the gastrointestinal market that set its products. The company was founded by Benad Goldwasser, Oz Cabiri and Yossi Gross in 2003 and is headquartered in Ramat Gan, Israel. | Medical Specialties | Director of Finance/CFO | |
| EXALENZ BIOSCIENCE LTD | Medical Specialties | Director of Finance/CFO | |
| REWALK ROBOTICS LTD. | Medical Specialties | Director of Finance/CFO | |
| The College of Management Academic Studies | College/University | Masters Business Admin Undergraduate Degree | |
KCS Ltd.
 KCS Ltd. Miscellaneous Commercial ServicesCommercial Services Part of TMF Group BV, KCS Ltd. provides accounting, auditing, and payroll services. The company is based in Hong Kong, Hong Kong. KCS was acquired by TMF Group BV from UCL Asia Ltd. on July 14, 2014. | Miscellaneous Commercial Services | Director of Finance/CFO | |
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Corporate Officer/Principal Sales & Marketing Chief Tech/Sci/R&D Officer | |
Insight Biopharmaceuticals Ltd.
 Insight Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Insight Biopharmaceuticals Ltd. is an Israeli company that manufactures and commercializes biosimilars and new antibody therapeutics. The private company is based in Rehovot, Israel. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Recoly NV
 Recoly NV Miscellaneous Commercial ServicesCommercial Services Recoly NV operates as a biotech company focusing on the discovery, development and commercialization of drug enhancing technologies that are used to create bio-better drugs. Its pipeline includes multiple products; all based on their proprietary technologies, in different development stages from marketing authorization filing through pivotal to pre-clinical studies. The company was founded by Robert Taub in 1992 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Founder | |
| University of Antwerp | College/University | Undergraduate Degree | |
| Harlan Biotech Israel Ltd. | Chief Tech/Sci/R&D Officer | ||
| University of Haifa | College/University | Graduate Degree | |
HighCape Partners Management LLC
 HighCape Partners Management LLC Investment ManagersFinance HighCape Partners Management LLC (HighCape Partners) is a private equity firm founded in 2013 by Kevin Rakin and Matt Zuga. The firm headquartered in Westport, Connecticut.. | Investment Managers | Consultant / Advisor | |
| The Hebrew University Hadassah Medical School | College/University | Doctorate Degree | |
| Columbia College (New York) | College/University | Undergraduate Degree | |
| Fu Foundation School of Engineering & Applied Science | College/University | Undergraduate Degree | |
Mitsubishi Tanabe Pharma Holdings America, Inc.
 Mitsubishi Tanabe Pharma Holdings America, Inc. Pharmaceuticals: OtherHealth Technology Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma Holdings America, Inc. manufactures and distributes pharmaceuticals, pet products & medicines. The company is based in Jersey City, NJ. | Pharmaceuticals: Other | President | |
Orphan Technologies Ltd.
 Orphan Technologies Ltd. Pharmaceuticals: MajorHealth Technology Orphan Technologies Ltd. engages in the manufacturing of biopharmaceutical drugs. It develops novel therapies for patients suffering from rare disorder and classical homocystinuria. The company is headquartered in Rapperswil, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
PDI, Inc.
 PDI, Inc. Commercial Printing/FormsCommercial Services PDI, Inc. provides format printing services. It specializes in document management, electronic pre-media and on-site prepress management, to offset and full-color variable digital print, bindery, multimedia and internet services. The company was founded in February 2007 and is headquartered in Kirkland, Canada. | Commercial Printing/Forms | Chief Executive Officer | |
Anima Biotech, Inc.
 Anima Biotech, Inc. Pharmaceuticals: MajorHealth Technology Anima Biotech, Inc. develops translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against hard and undruggable targets. The firm?s platform combines new biology with proprietory image analysis and big data software. The company was founded Yochi Slonim and Zeev Smilansky and is headquartered in Bernardsville, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pig For Life SA
 Pig For Life SA Agricultural Commodities/MillingProcess Industries Pig For Life SA is a Belgian company that specializes in breeding pigs. The company is based in Marche-en-Famenne, Belgium. | Agricultural Commodities/Milling | Director/Board Member | |
| NEUROSENSE THERAPEUTICS LTD. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
Mitsubishi Tanabe Pharma America, Inc.
 Mitsubishi Tanabe Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Part of Mitsubishi Chemical Group Corp., Mitsubishi Tanabe Pharma America, Inc. (MTPA) is a pharmaceutical company based in Jersey City, NJ. MTPA is a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC) and was established to develop and advance their pipeline as well as commercialize approved pharmaceutical products in the United States. MTPA delivers innovative solutions that are guided by patients' unmet medical needs. | Pharmaceuticals: Major | President | |
Nanocarry Therapeutics Ltd.
 Nanocarry Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Nanocarry Therapeutics Ltd. is a company based in Nes-Ziona, Israel. Nanocarry is developing a new class of therapeutics using bioengineered nanoparticles to treat oncology indications and brain diseases. The Israeli company's proprietary "plug and play" approach allows for easy modification to deliver a wide array of biologics safely and effectively to the brain and beyond. Nanocarry's first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer. The company aims to extend the reach of biological therapeutics to the brain to tackle CNS diseases head-on, pioneering a multidisciplinary approach that overcomes the blood-brain barrier. The company was founded by Rachela Popovtzer, Oshra Betzer, and Revital Mandil-Levin, with Revital Mandil-Levin serving as the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
| AYALA PHARMACEUTICALS, INC. | Miscellaneous Commercial Services | Director of Finance/CFO |
Statistieken
Internationaal
| Israël | 27 |
| Verenigde Staten | 15 |
| België | 4 |
| Frankrijk | 3 |
| Japan | 2 |
Sectoraal
| Health Technology | 21 |
| Consumer Services | 16 |
| Commercial Services | 7 |
| Finance | 3 |
| Process Industries | 3 |
Operationeel
| Director/Board Member | 27 |
| Corporate Officer/Principal | 22 |
| Chief Tech/Sci/R&D Officer | 11 |
| Chief Executive Officer | 9 |
| Director of Finance/CFO | 9 |
Sterkste connecties
- Beurs
- Insiders
- Ziva Mesika
- Bedrijfsconnecties
